Publicaciones (24) Publicaciones de PATRICIA DIEZHANDINO GARCIA

2024

  1. Status of head and neck brachytherapy in Spain in 2022

    Clinical and Translational Oncology, Vol. 26, Núm. 2, pp. 456-460

2023

  1. A study comparing baseline and best-corrected visual acuity after iodine-125 episcleral brachytherapy in uveal melanoma

    Journal of Contemporary Brachytherapy, Vol. 15, Núm. 5, pp. 350-356

  2. Brachytherapy in the prevention of recurrence of conjunctival melanoma: Results of a case report in a University Hospital in Valladolid, Spain

    Strahlentherapie und Onkologie, Vol. 199, Núm. 11, pp. 1025-1030

2021

  1. Regression of posterior uveal melanoma following iodine-125 plaque radiotherapy based on pre-treatment tumor apical height

    Journal of Contemporary Brachytherapy, Vol. 13, Núm. 2, pp. 117-125

2020

  1. Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR)

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1378-1389

2019

  1. Treatment planning considerations for 125I eye plaque brachytherapy

    Journal of Contemporary Brachytherapy, Vol. 11, Núm. 3, pp. 280-284

2018

  1. Metástasis intraoculares: comparación entre las formas de presentación clínica con tumor primario conocido y desconocido

    Archivos de la Sociedad Española de Oftalmologia, Vol. 93, Núm. 1, pp. 7-14

  2. Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part I

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 4, pp. 337-346

  3. Radiobiological doses, tumor, and treatment features influence on outcomes after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: Part II

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 4, pp. 347-359

  4. Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses

    Journal of Contemporary Brachytherapy, Vol. 10, Núm. 2, pp. 123-131

2017

  1. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit

    American Journal of Ophthalmology, Vol. 180, pp. 39-45

2016

  1. 5-Fluorouracil, 5-Fluracil, Fluorouracil, Fu

    The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 479-486

  2. Capecitabina. Xeloda®

    The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 77-84

  3. Denosumab, Prolia®, Xgeva®

    The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 131-138

  4. Linfoma folicular primario de la conjuntiva simulando conjuntivitis crónica

    Archivos de la Sociedad Española de Oftalmologia, Vol. 91, Núm. 2, pp. 86-89

  5. Zoledronic Acid, Zometa®, Aclasta®, Reclast®

    The Easy Book of Cancer Pharmacology (Nova Science Publishers, Inc.), pp. 469-477

2013

  1. Tumor pigmentado del cuerpo ciliar: ¿benigno o maligno?

    Archivos de la Sociedad Española de Oftalmologia, Vol. 88, Núm. 12, pp. 485-488

2010

  1. Parkinsonism secondary to metastatic lesions within the central nervous system: A case report

    Journal of Medical Case Reports, Vol. 4

2004

  1. Diseño, análisis y presentación de estudios: Sembrar para luego recoger

    Medicina Paliativa, Vol. 11, Núm. 1, pp. 35-42

  2. Medida de la eficacia de las intervenciones clínicas

    Medicina Paliativa, Vol. 11, Núm. 3, pp. 164-173